Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva made smart decision to move to us: Allergan CEO
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Drugmaker Teva latest to settle opioid lawsuits nationally - POLITICO
New York could get $524M under opioid settlements with Teva - ABC News
Teva CEO Schultz likely won't renew employment contract: reports
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
teva News and latest stories | The Jerusalem Post
Here's Why Teva Shares are Trending Higher Today
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
